Fig. 7From: In silico analysis of HLA-1 and HLA-2 recognition of a designed recombinant human papillomavirus vaccine based on L1 protein HPV subtype 45The position of antigenic peptides (shown in colorful beads) with VaxiJen antigenicity scores >1 which are predicted to bind with HLA-DRB1 from A general population (TDLYIKGTSANMRETP) and B West Java population (FLVQAGLRRRPTIGPRKRPAAS)Back to article page